Purpose
We compared the phonological accuracy and speech intelligibility of boys with fragile X syndrome with autism spectrum disorder (FXS-ASD), fragile X syndrome only (FXS-O), Down Syndrome (DS), and typically developing (TD) boys.
Method
Participants were 32 boys with FXS-O (3 to 14 years), 31 with FXS-ASD (5 to 15 years), 34 with DS (4 to16 years), and 45 TD boys of similar nonverbal mental age. We used connected speech samples to compute measures of phonological accuracy, phonological process occurrence, and intelligibility.
Results
The boys with FXS, regardless of autism status, did not differ from TD boys on phonological accuracy and phonological process occurrence but produced fewer intelligible words than TD boys. The boys with DS scored lower on measures of phonological accuracy and occurrence of phonological processes than all other groups and used fewer intelligible words than TD boys. The boys with FXS and the boys with DS did not differ on measures of intelligibility.
Conclusion
Boys with FXS, regardless of autism status, exhibit phonological characteristics similar to those of younger TD children but are less intelligible in connected speech. The boys with DS show greater delays in all phonological measures than the boys with FXS and TD boys.
Young boys with autism were compared to typically developing boys on responses to nonsocial and child-directed speech (CDS) stimuli. Behavioral (looking) and physiological (heart rate and respiratory sinus arrhythmia) measures were collected. Boys with autism looked equally as much as chronological age-matched peers at nonsocial stimuli, but less at CDS stimuli. Boys with autism and language age-matched peers differed in patterns of looking at live versus videotaped CDS stimuli. Boys with autism demonstrated faster heart rates than chronological age-matched peers, but did not differ significantly on respiratory sinus arrhythmia. Reduced attention during CDS may restrict language-learning opportunities for children with autism. The heart rate findings suggest that young children with autism have a nonspecific elevated arousal level.
This study was designed to examine the feasibility of using the spectral mean and/or spectral skewness to distinguish between alveolar and palato-alveolar fricatives produced by individual adult speakers of English. Five male and five female speaker participants produced 100 CVC words with an initial consonant /s/ or /ʃ/. The spectral mean and skewness were derived every 10 milliseconds throughout the fricative segments and plotted for all productions. Distinctions were examined for each speaker through visual inspection of these time history plots and statistical comparisons were completed for analysis windows centered 50 ms after the onset of the fricative segment. The results showed significant differences between the alveolar and palato-alveolar fricatives for both the mean and skewness values. However, there was considerable inter-speaker overlap, limiting the utility of the measures to evaluate the adequacy of the phonetic distinction. When the focus shifted to individual speakers rather than average group performance, only the spectral mean distinguished consistently between the two phonetic categories. The robustness of the distinction suggests that intra-speaker overlap in spectral mean between prevocalic /s/ and /ʃ/ targets may be indicative of abnormal fricative production and a useful measure for clinical applications.
SPL appears to largely account for percentage nasalance differences between the vowels /i/ and /a/ produced by adult male and female speakers. Increased F0 by male speakers appears to influence percentage nasalance during production of the vowel /a/. Clinical implications in regard to assessment of hypernasality are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.